Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity

Kaori Kanemaru, Yoshikazu Nakamura, Kengo Totoki, Takatsugu Fukuyama, Madoka Shoji, Hisae Kaneko, Kanako Shiratori, Atsuko Yoneda, Takafumi Inoue, Yoichiro Iwakura, Kenji Kabashima, Kiyoko Fukami

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Keratinocytes undergo a unique type of programmed cell death known as cornification, which leads to the formation of the stratum corneum (SC), the main physical barrier of the epidermis. A defective epidermal barrier is a hallmark of the two most common inflammatory skin disorders, psoriasis, and atopic dermatitis. However, the detailed molecular mechanisms of skin barrier formation are not yet fully understood. Here, we showed that downregulation of phospholipase C (PLC) d 1, a Ca 2+-mobilizing and phosphoinositide-metabolizing enzyme abundantly expressed in the epidermis, impairs the barrier functions of the SC. PLCd 1 downregulation also impairs localization of tight junction proteins. Loss of PLCd 1 leads to a decrease in intracellular Ca 2+ concentrations and nuclear factor of activated T cells activity, along with hyperactivation of p38 mitogen-activated protein kinase (MAPK) and inactivation of RhoA. Treatment with a p38 MAPK inhibitor reverses the barrier defects caused by PLCd 1 downregulation. Interestingly, this treatment also attenuates psoriasis-like skin inflammation in imiquimod-treated mice. These findings demonstrate that PLCd 1 is essential for epidermal barrier integrity. This study also suggests a possible link between PLCd 1 downregulation, p38 MAPK hyperactivation, and barrier defects in psoriasis-like skin inflammation.

    Original languageEnglish
    Pages (from-to)1079-1090
    Number of pages12
    JournalCell Death and Differentiation
    Volume24
    Issue number6
    DOIs
    Publication statusPublished - 2017 Jun 1

    Fingerprint

    Type C Phospholipases
    p38 Mitogen-Activated Protein Kinases
    Down-Regulation
    Psoriasis
    Skin
    Epidermis
    imiquimod
    Cornea
    NFATC Transcription Factors
    Inflammation
    Tight Junction Proteins
    Architectural Accessibility
    Atopic Dermatitis
    Protein Kinase Inhibitors
    Phosphatidylinositols
    Keratinocytes
    Cell Death
    Enzymes

    ASJC Scopus subject areas

    • Molecular Biology
    • Cell Biology

    Cite this

    Kanemaru, K., Nakamura, Y., Totoki, K., Fukuyama, T., Shoji, M., Kaneko, H., ... Fukami, K. (2017). Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity. Cell Death and Differentiation, 24(6), 1079-1090. https://doi.org/10.1038/cdd.2017.56

    Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity. / Kanemaru, Kaori; Nakamura, Yoshikazu; Totoki, Kengo; Fukuyama, Takatsugu; Shoji, Madoka; Kaneko, Hisae; Shiratori, Kanako; Yoneda, Atsuko; Inoue, Takafumi; Iwakura, Yoichiro; Kabashima, Kenji; Fukami, Kiyoko.

    In: Cell Death and Differentiation, Vol. 24, No. 6, 01.06.2017, p. 1079-1090.

    Research output: Contribution to journalArticle

    Kanemaru, K, Nakamura, Y, Totoki, K, Fukuyama, T, Shoji, M, Kaneko, H, Shiratori, K, Yoneda, A, Inoue, T, Iwakura, Y, Kabashima, K & Fukami, K 2017, 'Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity', Cell Death and Differentiation, vol. 24, no. 6, pp. 1079-1090. https://doi.org/10.1038/cdd.2017.56
    Kanemaru K, Nakamura Y, Totoki K, Fukuyama T, Shoji M, Kaneko H et al. Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity. Cell Death and Differentiation. 2017 Jun 1;24(6):1079-1090. https://doi.org/10.1038/cdd.2017.56
    Kanemaru, Kaori ; Nakamura, Yoshikazu ; Totoki, Kengo ; Fukuyama, Takatsugu ; Shoji, Madoka ; Kaneko, Hisae ; Shiratori, Kanako ; Yoneda, Atsuko ; Inoue, Takafumi ; Iwakura, Yoichiro ; Kabashima, Kenji ; Fukami, Kiyoko. / Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity. In: Cell Death and Differentiation. 2017 ; Vol. 24, No. 6. pp. 1079-1090.
    @article{b406ef08480449f486f18288245a0e24,
    title = "Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity",
    abstract = "Keratinocytes undergo a unique type of programmed cell death known as cornification, which leads to the formation of the stratum corneum (SC), the main physical barrier of the epidermis. A defective epidermal barrier is a hallmark of the two most common inflammatory skin disorders, psoriasis, and atopic dermatitis. However, the detailed molecular mechanisms of skin barrier formation are not yet fully understood. Here, we showed that downregulation of phospholipase C (PLC) d 1, a Ca 2+-mobilizing and phosphoinositide-metabolizing enzyme abundantly expressed in the epidermis, impairs the barrier functions of the SC. PLCd 1 downregulation also impairs localization of tight junction proteins. Loss of PLCd 1 leads to a decrease in intracellular Ca 2+ concentrations and nuclear factor of activated T cells activity, along with hyperactivation of p38 mitogen-activated protein kinase (MAPK) and inactivation of RhoA. Treatment with a p38 MAPK inhibitor reverses the barrier defects caused by PLCd 1 downregulation. Interestingly, this treatment also attenuates psoriasis-like skin inflammation in imiquimod-treated mice. These findings demonstrate that PLCd 1 is essential for epidermal barrier integrity. This study also suggests a possible link between PLCd 1 downregulation, p38 MAPK hyperactivation, and barrier defects in psoriasis-like skin inflammation.",
    author = "Kaori Kanemaru and Yoshikazu Nakamura and Kengo Totoki and Takatsugu Fukuyama and Madoka Shoji and Hisae Kaneko and Kanako Shiratori and Atsuko Yoneda and Takafumi Inoue and Yoichiro Iwakura and Kenji Kabashima and Kiyoko Fukami",
    year = "2017",
    month = "6",
    day = "1",
    doi = "10.1038/cdd.2017.56",
    language = "English",
    volume = "24",
    pages = "1079--1090",
    journal = "Cell Death and Differentiation",
    issn = "1350-9047",
    publisher = "Nature Publishing Group",
    number = "6",

    }

    TY - JOUR

    T1 - Phospholipase Cδ 1 regulates p38 MAPK activity and skin barrier integrity

    AU - Kanemaru, Kaori

    AU - Nakamura, Yoshikazu

    AU - Totoki, Kengo

    AU - Fukuyama, Takatsugu

    AU - Shoji, Madoka

    AU - Kaneko, Hisae

    AU - Shiratori, Kanako

    AU - Yoneda, Atsuko

    AU - Inoue, Takafumi

    AU - Iwakura, Yoichiro

    AU - Kabashima, Kenji

    AU - Fukami, Kiyoko

    PY - 2017/6/1

    Y1 - 2017/6/1

    N2 - Keratinocytes undergo a unique type of programmed cell death known as cornification, which leads to the formation of the stratum corneum (SC), the main physical barrier of the epidermis. A defective epidermal barrier is a hallmark of the two most common inflammatory skin disorders, psoriasis, and atopic dermatitis. However, the detailed molecular mechanisms of skin barrier formation are not yet fully understood. Here, we showed that downregulation of phospholipase C (PLC) d 1, a Ca 2+-mobilizing and phosphoinositide-metabolizing enzyme abundantly expressed in the epidermis, impairs the barrier functions of the SC. PLCd 1 downregulation also impairs localization of tight junction proteins. Loss of PLCd 1 leads to a decrease in intracellular Ca 2+ concentrations and nuclear factor of activated T cells activity, along with hyperactivation of p38 mitogen-activated protein kinase (MAPK) and inactivation of RhoA. Treatment with a p38 MAPK inhibitor reverses the barrier defects caused by PLCd 1 downregulation. Interestingly, this treatment also attenuates psoriasis-like skin inflammation in imiquimod-treated mice. These findings demonstrate that PLCd 1 is essential for epidermal barrier integrity. This study also suggests a possible link between PLCd 1 downregulation, p38 MAPK hyperactivation, and barrier defects in psoriasis-like skin inflammation.

    AB - Keratinocytes undergo a unique type of programmed cell death known as cornification, which leads to the formation of the stratum corneum (SC), the main physical barrier of the epidermis. A defective epidermal barrier is a hallmark of the two most common inflammatory skin disorders, psoriasis, and atopic dermatitis. However, the detailed molecular mechanisms of skin barrier formation are not yet fully understood. Here, we showed that downregulation of phospholipase C (PLC) d 1, a Ca 2+-mobilizing and phosphoinositide-metabolizing enzyme abundantly expressed in the epidermis, impairs the barrier functions of the SC. PLCd 1 downregulation also impairs localization of tight junction proteins. Loss of PLCd 1 leads to a decrease in intracellular Ca 2+ concentrations and nuclear factor of activated T cells activity, along with hyperactivation of p38 mitogen-activated protein kinase (MAPK) and inactivation of RhoA. Treatment with a p38 MAPK inhibitor reverses the barrier defects caused by PLCd 1 downregulation. Interestingly, this treatment also attenuates psoriasis-like skin inflammation in imiquimod-treated mice. These findings demonstrate that PLCd 1 is essential for epidermal barrier integrity. This study also suggests a possible link between PLCd 1 downregulation, p38 MAPK hyperactivation, and barrier defects in psoriasis-like skin inflammation.

    UR - http://www.scopus.com/inward/record.url?scp=85019919574&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85019919574&partnerID=8YFLogxK

    U2 - 10.1038/cdd.2017.56

    DO - 10.1038/cdd.2017.56

    M3 - Article

    VL - 24

    SP - 1079

    EP - 1090

    JO - Cell Death and Differentiation

    JF - Cell Death and Differentiation

    SN - 1350-9047

    IS - 6

    ER -